↓ Skip to main content

Dove Medical Press

Article Metrics

Current concepts in multiple sclerosis therapy

Overview of attention for article published in Degenerative Neurological and Neuromuscular Disease, September 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)

Mentioned by

twitter
4 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
41 Mendeley
Title
Current concepts in multiple sclerosis therapy
Published in
Degenerative Neurological and Neuromuscular Disease, September 2017
DOI 10.2147/dnnd.s109251
Pubmed ID
Authors

Leslie Sedal, Antony Winkel, Joshua Laing, Lai Yin Law, Elizabeth McDonald

Abstract

Over the past 20 years, the available therapies for multiple sclerosis have expanded exponentially. With several more agents likely to be approved for public funding in Australia in the next 12 months on top of the existing multitude of Australian Pharmaceutical Benefits Scheme-subsidized therapies, the choice is becoming even more complex. This review summarizes the current state of available therapies and anticipates likely future directions, including an important focus on contemporary symptom management. For each agent, the major trials, side effects, and clinical utility are summarized, with a particular focus on the Australian experience of these therapies. It is hoped this review provides an up-to-date reference of the exciting current state of multiple sclerosis therapy.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 22%
Student > Bachelor 6 15%
Researcher 5 12%
Student > Ph. D. Student 3 7%
Student > Doctoral Student 2 5%
Other 7 17%
Unknown 9 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 17%
Medicine and Dentistry 5 12%
Agricultural and Biological Sciences 4 10%
Neuroscience 3 7%
Nursing and Health Professions 2 5%
Other 6 15%
Unknown 14 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2017.
All research outputs
#6,119,885
of 11,877,834 outputs
Outputs from Degenerative Neurological and Neuromuscular Disease
#16
of 43 outputs
Outputs of similar age
#104,485
of 270,660 outputs
Outputs of similar age from Degenerative Neurological and Neuromuscular Disease
#1
of 1 outputs
Altmetric has tracked 11,877,834 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 43 research outputs from this source. They receive a mean Attention Score of 5.0. This one scored the same or higher as 27 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,660 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them